Search

Abeona Therapeutics Inc

Slēgts

5.56 -0.54

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

5.55

Max

5.63

Galvenie mērījumi

By Trading Economics

Ienākumi

-3.1M

-20M

Pārdošana

2.7M

11M

P/E

Sektora vidējais

7.451

56.432

Peļņas marža

-177.425

Darbinieki

226

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+294.97% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 11. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-23M

261M

Iepriekšējā atvēršanas cena

6.1

Iepriekšējā slēgšanas cena

5.56

Abeona Therapeutics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 20. sept. 23:51 UTC

BoJ Meeting Minutes on September 27 Expected to Influence Japan's Interest Rate Outlook Amid Global Economic Uncertainties.

2026. g. 20. sept. 23:11 UTC

PBOC Holds Loan Prime Rate Steady at 3.00% Amid Economic Caution and Mixed Signals in China

2026. g. 20. sept. 23:01 UTC

Macro News
Correlated Moves

The Dow Jones Index is advancing as the People's Bank of China maintains its Loan Prime Rates amid cautious market conditions and geopolitical tensions.

2026. g. 20. sept. 23:01 UTC

Correlated Moves
Macro News

The S&P 500 Index is advancing amid macroeconomic developments, including China's unchanged Loan Prime Rates and mixed industrial production and retail sales data.

2026. g. 20. sept. 23:01 UTC

Macro News
Correlated Moves

The Nasdaq 100 Index is advancing, supported by the Russell 2000's rise and the People's Bank of China's decision to maintain its Loan Prime Rate at 3.00%.

2026. g. 20. sept. 23:01 UTC

Correlated Moves
Macro News

The Russell 2000 Index is modestly higher, reflecting a stable market backdrop amid China's unchanged Loan Prime Rate and geopolitical tensions.

2026. g. 20. sept. 23:00 UTC

Macro News

Oil (WTI) is advancing amid heightened geopolitical tensions following Houthi attacks in Saudi Arabia and ongoing U.S. energy policy discussions, despite earlier session pullbacks.

2026. g. 20. sept. 23:00 UTC

The EUR/NOK is declining as trading resumes for the week, influenced by ongoing geopolitical tensions in the Middle East and U.S.-Iran relations.

2026. g. 20. sept. 23:00 UTC

The EUR/CHF is slightly lower in early trading this week, reflecting routine fluctuations amid ongoing geopolitical tensions, particularly in the Middle East.

2026. g. 20. sept. 23:00 UTC

The EUR/CZK is slightly lower as trading resumes for the week, reflecting geopolitical tensions affecting financial markets despite remaining near the upper end of its one-month range.

2026. g. 20. sept. 23:00 UTC

Avalanche is experiencing a sharp increase in value, maintaining a position well above its 20-day moving average amid ongoing geopolitical tensions.

2026. g. 20. sept. 22:51 UTC

U.S. 30-Year Mortgage Rate Hits Highest Level Since May at 6.97%, Sparking Concerns Over Housing Demand Amid Rising Treasury Yields and Inflation Fears

2026. g. 20. sept. 22:51 UTC

Chicago Fed National Activity Index Release on September 21, 2026, Anticipates Continued Economic Uncertainty Amid Recent Volatility.

2026. g. 20. sept. 22:11 UTC

UK Consumer Confidence Index Set for Release Amid Mixed Sentiment and Economic Concerns, Forecast at -16.0

2026. g. 20. sept. 22:01 UTC

Correlated Moves

The AUD/USD is slightly lower in early trading, reflecting a cautious investor outlook amid ongoing Middle East conflict and recent interest rate hikes.

2026. g. 20. sept. 22:00 UTC

The EUR/PLN is advancing in early trading, reflecting a notable increase since Friday's close amid ongoing geopolitical tensions and central bank interest rate hikes.

2026. g. 20. sept. 21:21 UTC

Australia's S&P Global Manufacturing PMI Flash set for September 22, with cautious optimism amid global economic pressures.

2026. g. 20. sept. 21:21 UTC

Australia's S&P Global Services PMI Flash set for September 22, with cautious optimism amid global market influences.

2026. g. 20. sept. 21:01 UTC

Brazil's Central Bank to Release Key Market Readout on Interest Rates and Economic Forecasts on September 21, 2026.

2026. g. 20. sept. 20:51 UTC

UK CBI Distributive Trades Forecasts Sharp Decline in Retail Sales Sentiment at -50.0 Amid Ongoing Consumer Spending Downturn

2026. g. 20. sept. 20:21 UTC

UK Factory Orders Show Resilience with Improved Order Book Balance, Yet Forecasts Indicate Continued Decline Amid Economic Challenges.

2026. g. 20. sept. 20:21 UTC

API Crude Oil Stock Change Report on September 22, 2026, Expected to Reveal Rising U.S. Inventories Amid Geopolitical Tensions Impacting Market Sentiment.

2026. g. 20. sept. 19:21 UTC

South Korea's Consumer Confidence Index Release on September 22 Expected to Reflect Cautious Optimism Amid Economic Volatility.

2026. g. 20. sept. 18:51 UTC

Germany's Ifo Business Climate Index set to release with a forecast of 89.2, reflecting cautious optimism amid geopolitical tensions and inflationary pressures.

2026. g. 20. sept. 18:51 UTC

South Africa's Inflation Rate MoM Release on September 23, 2026 Expected to Reflect Global Economic Trends Amid Rising Concerns.

2026. g. 20. sept. 18:51 UTC

South Africa's Inflation Rate Release on September 23, 2026, Expected to Reflect Economic Pressures Amid Rising Costs and Geopolitical Tensions.

2026. g. 20. sept. 18:41 UTC

Cautious Optimism for Euro Area Manufacturing as S&P Global PMI Flash Set to Show Growth at 52.9 Amid Geopolitical Challenges

2026. g. 20. sept. 18:41 UTC

Spain's Balance of Trade Data Set for Release Amidst Ongoing Trade Deficits and Rising Import Costs, Raising Inflation Concerns in the Eurozone.

2026. g. 20. sept. 18:41 UTC

Swiss National Bank Expected to Maintain Zero Interest Rate Amid Subdued Inflation and Modest Economic Growth

2026. g. 20. sept. 18:41 UTC

French Services PMI Flash Expected at 48.5 Amid Political and Economic Concerns, Signaling Continued Contraction

Salīdzinājums

Cenas izmaiņa

Abeona Therapeutics Inc Prognoze

Cenas mērķis

By TipRanks

294.97% augšup

Prognoze 12 mēnešiem

Vidējais 22 USD  294.97%

Augstākais 30 USD

Zemākais 17 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Abeona Therapeutics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

4 ratings

4

Pirkt

0

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

Pamatdarbības peļņa

$

Par Abeona Therapeutics Inc

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in Cleveland, Ohio.